FDA warns blood pressure drugs investigation for cancer-causing chemical

The FDA is investigating a broader set of medications that may be repackaged valsartan after recalling the popular blood pressure drug over its discovery that it contains a carcinogen, the agency said today.

from Health | Mail Online https://ift.tt/2C4XRPS